Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Beta-Glucans wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
14 of 16 studies with measurable effects showed benefit.
Top outcomes
Verdict
Mostly mechanism / observational
250-500mg yeast beta-glucan OR 3g oat beta-glucan for cholesterol
Morning, With or without food
Yeast-derived 1,3/1,6 beta-glucan (Wellmune is most studied)
Liquid EPs 7630: 30 drops three times daily for adults during an acute infection
spread-through-day
Liquid extract (EPs 7630)
4-12 weeks
During illness
4-8 weeks
Days 4-7 of an acute episode
Within the acute illness window
During use
Galactomannans are the most effective soluble dietary fibers in type 2 diabetes: a systematic review and network meta-analysis
The American journal of clinical nutrition (2023) · Meta analysis · n=2685
Galactomannans had the highest effect on reducing the levels of HbA1c (SUCRA: 92.33%) and fasting blood glucose (SUCRA: 85.92%).
Effects of Oat Beta-Glucan Intake on Lipid Profiles in Hypercholesterolemic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Nutrients (2022) · Meta analysis · n=927
The results were presented with the weighted mean difference (WMD) with a 95% CI.
A systematic review and meta-analysis of beta-glucan consumption on glycemic control in hypercholesterolemic individuals
International journal of food sciences and nutrition (2015) · Meta analysis · n=603
Summary estimates of weighted mean differences (WMD) and 95% confidence interval was 0.05 mmol/L (-0.11, 0.02) for fasting glucose concentration and 0.75 pmol/L (-1.82, 3.32) for fasting insulin concentrations.
Pelargonium sidoides extract for treating acute respiratory tract infections.
Cochrane Database Syst Rev (2013) · Systematic review · n=10 trials; ~746 adults and ~819 children
Liquid EPs 7630 showed effectiveness for acute bronchitis in both adults and children; tablets did not
Treatment of acute bronchitis with EPs 7630: randomized, controlled trial in children and adolescents.
Pediatr Int (2012) · Rct · n=220 children/adolescents
Significantly greater BSS reduction with EPs 7630 versus placebo (P<0.0001)
Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides.
Wien Med Wochenschr (2010) · Rct · n=406 adults
All three active dose groups improved patient-reported outcomes versus placebo at day 7
Based on multiple meta-analyses showing 0.24-0.32 mmol/L LDL reduction. Effect specific to oat beta-glucan, not yeast forms. FDA-approved health claim at 3g dose. GI side effects more common with oat forms.
AI-estimated from published studies. Interpret as directional guidance.
Beta-Glucans has a higher evidence score (7/10 vs 6.5/10) and wins in 3 of 3 categories.
For support immune system, Beta-Glucans has a higher relevance score (95 vs 62).
No known interactions between Beta-Glucans and Pelargonium Sidoides have been documented in our database. However, always consult a healthcare provider before combining supplements.